The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Presentations Included First Human Data on EVAâ„¢, Saluda's Automated SCS Programming Platform MINNEAPOLIS, Feb. 5, 2025 ...
Christian Fellowship Center Lead Pastor Brian Dube is making a miraculous recovery from a case of near-fatal paralysis from a ...
In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...
Seven women filed for re-sentencing under the Oklahoma Survivors Act, a new law that considers domestic violence evidence.
Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...